v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Total revenue $ 25,118 $ 1,031 $ 35,852 $ 1,392
Operating expenses:        
Cost of product revenue 154 0 354 0
Research and development 99,850 80,301 199,931 156,541
Selling, general and administrative 57,573 49,842 108,404 85,368
Total operating expenses 157,577 130,143 308,689 241,909
Loss from operations (132,459) (129,112) (272,837) (240,517)
Other income (expense):        
Interest income 12,027 13,455 24,691 28,289
Other (expense) income, net (423) 20 (554) (183)
Total other income, net 11,604 13,475 24,137 28,106
Net loss $ (120,855) $ (115,637) $ (248,700) $ (212,411)
Net loss per share:        
Net loss per share - basic (in dollar per share) $ (1.14) $ (1.23) $ (2.37) $ (2.27)
Net loss per share - diluted (in dollar per share) $ (1.14) $ (1.23) $ (2.37) $ (2.27)
Weighted average shares - basic (in shares) 105,560 93,791 104,834 93,448
Weighted average shares - diluted (in shares) 105,560 93,791 104,834 93,448
Other comprehensive income (loss):        
Unrealized gain (loss) on investment securities $ (1,899) $ (347) $ (5,046) $ 686
Unrealized gain (loss) on foreign currency 145 (34) 173 (28)
Total other comprehensive income (loss) (1,754) (381) (4,873) 658
Comprehensive loss (122,609) (116,018) (253,573) (211,753)
Product revenue, net        
Total revenue 24,038 0 34,344 0
Collaboration and license revenue        
Total revenue $ 1,080 $ 1,031 $ 1,508 $ 1,392